Dr. Anne Phelan
Appointed to role
April 2022, previously in this role at BenevolentAI Ltd since September 2019.
Skills and experience
Anne has over 25 years of experience in pharma and biotech and has worked on drug development, from early discovery to late stage and across a wide range of therapeutic areas including fibrosis, pain, arthritis and rheumatology, and neurodegeneration.
Before joining BenevolentAI, Anne worked for Pfizer where she was head of pharmacology and chief operating officer for Pfizer, UK, and where she was responsible for the generation of primary and secondary data to support the portfolio. Prior to that, she was executive vice president head of research at the biotech Mission Therapeutics.
Anne holds a Bachelor of Science and PhD in Genetics from the University of Liverpool.